Tower Research Capital LLC (Trc) Uni Qure N.V. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Uni Qure N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,069 shares of QURE stock, worth $11,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,069

Previous 5,490 62.31%

Holding current value

$11,793

Previous $24,000 58.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.78 - $10.12 $12,931 - $34,620	-3,421 Reduced 62.31%	2,069 $10,000
Q2 2024 Aug 13, 2024	SELL	$4.39 - $5.43 $33,706 - $41,691	-7,678 Reduced 58.31%	5,490 $24,000
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $50,152 - $72,106	10,405 Added 376.58%	13,168 $68,000
Q4 2023 Feb 13, 2024	SELL	$5.63 - $8.27 $68,714 - $100,935	-12,205 Reduced 81.54%	2,763 $18,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $83,526 - $147,259	12,448 Added 493.97%	14,968 $100,000
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $63,517 - $126,806	-5,712 Reduced 69.39%	2,520 $28,000
Q1 2023 May 09, 2023	SELL	$18.7 - $23.07 $65,767 - $81,137	-3,517 Reduced 29.93%	8,232 $166,000
Q4 2022 Feb 10, 2023	BUY	$18.12 - $27.32 $173,752 - $261,971	9,589 Added 443.94%	11,749 $267,000
Q3 2022 Nov 10, 2022	SELL	$16.98 - $25.54 $164,706 - $247,738	-9,700 Reduced 81.79%	2,160 $40,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $89,143 - $138,630	-6,779 Reduced 36.37%	11,860 $221,000
Q1 2022 May 12, 2022	BUY	$14.54 - $21.5 $187,217 - $276,834	12,876 Added 223.43%	18,639 $337,000
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $7,711 - $13,719	381 Added 7.08%	5,763 $120,000
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $116,030 - $170,499	4,461 Added 484.36%	5,382 $172,000
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $14,505 - $17,990	484 Added 110.76%	921 $28,000
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $337,224 - $484,731	-11,533 Reduced 96.35%	437 $15,000
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $385,774 - $552,961	10,913 Added 1032.45%	11,970 $432,000
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $8,959 - $11,867	-249 Reduced 19.07%	1,057 $39,000
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $58,848 - $88,468	1,306 New	1,306 $59,000
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $70,257 - $129,891	-1,756 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$37.13 - $74.62 $62,081 - $124,764	1,672 Added 1990.48%	1,756 $126,000
Q3 2019 Nov 05, 2019	BUY	$39.36 - $76.8 $3,306 - $6,451	84 New	84 $3,000
Q2 2019 Aug 13, 2019	SELL	$52.76 - $82.19 $69,221 - $107,833	-1,312 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$27.39 - $68.41 $33,908 - $84,691	1,238 Added 1672.97%	1,312 $78,000
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $1,687 - $2,510	74 New	74 $2,000

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Uni Qure N.V. Transaction History